Black Rock Inc. Co Diagnostics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CODX
# of Institutions
46Shares Held
4.23MCall Options Held
22.9KPut Options Held
30.4K-
Vanguard Group Inc Valley Forge, PA1.78MShares$2.23 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny600KShares$750,5000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA294KShares$368,0270.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$341,1250.01% of portfolio
-
Kestra Advisory Services, LLC149KShares$186,1760.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $42.2M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...